Index by author
January 01, 2013; Volume 65,Issue 1
B
Bardo, M. T.
- You have accessIndividual Differences and Social Influences on the Neurobehavioral Pharmacology of Abused DrugsM. T. Bardo, J. L. Neisewander and T. H. KellyMichael A. Nader, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 255-290; DOI: https://doi.org/10.1124/pr.111.005124
Bernstein, Kenneth E.
- You have accessA Modern Understanding of the Traditional and Nontraditional Biological Functions of Angiotensin-Converting EnzymeKenneth E. Bernstein, Frank S. Ong, Wendell-Lamar B. Blackwell, Kandarp H. Shah, Jorge F. Giani, Romer A. Gonzalez-Villalobos, Xiao Z. Shen and Sebastien FuchsRhian M. Touyz, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 1-46; DOI: https://doi.org/10.1124/pr.112.006809
Blackwell, Wendell-Lamar B.
- You have accessA Modern Understanding of the Traditional and Nontraditional Biological Functions of Angiotensin-Converting EnzymeKenneth E. Bernstein, Frank S. Ong, Wendell-Lamar B. Blackwell, Kandarp H. Shah, Jorge F. Giani, Romer A. Gonzalez-Villalobos, Xiao Z. Shen and Sebastien FuchsRhian M. Touyz, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 1-46; DOI: https://doi.org/10.1124/pr.112.006809
Brotchie, Jonathan M.
- You have accessThe Pharmacology of l-DOPA-Induced Dyskinesia in Parkinson’s DiseasePhilippe Huot, Tom H. Johnston, James B. Koprich, Susan H. Fox and Jonathan M. BrotchieDavid R. Sibley, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 171-222; DOI: https://doi.org/10.1124/pr.111.005678
C
Charman, Susan A.
- You have accessStrategies to Address Low Drug Solubility in Discovery and DevelopmentHywel D. Williams, Natalie L. Trevaskis, Susan A. Charman, Ravi M. Shanker, William N. Charman, Colin W. Pouton and Christopher J. H. PorterArthur Christopoulos, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 315-499; DOI: https://doi.org/10.1124/pr.112.005660
Charman, William N.
- You have accessStrategies to Address Low Drug Solubility in Discovery and DevelopmentHywel D. Williams, Natalie L. Trevaskis, Susan A. Charman, Ravi M. Shanker, William N. Charman, Colin W. Pouton and Christopher J. H. PorterArthur Christopoulos, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 315-499; DOI: https://doi.org/10.1124/pr.112.005660
Chavkin, Charles
- You have accessRegulation of µ-Opioid Receptors: Desensitization, Phosphorylation, Internalization, and ToleranceJohn T. Williams, Susan L. Ingram, Graeme Henderson, Charles Chavkin, Mark von Zastrow, Stefan Schulz, Thomas Koch, Christopher J. Evans and MacDonald J. ChristieAnnette C. Dolphin, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 223-254; DOI: https://doi.org/10.1124/pr.112.005942
Chiu, Chi-Tso
- You have accessTherapeutic Potential of Mood Stabilizers Lithium and Valproic Acid: Beyond Bipolar DisorderChi-Tso Chiu, Zhifei Wang, Joshua G. Hunsberger and De-Maw ChuangDavid R. Sibley, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 105-142; DOI: https://doi.org/10.1124/pr.111.005512
Christie, MacDonald J.
- You have accessRegulation of µ-Opioid Receptors: Desensitization, Phosphorylation, Internalization, and ToleranceJohn T. Williams, Susan L. Ingram, Graeme Henderson, Charles Chavkin, Mark von Zastrow, Stefan Schulz, Thomas Koch, Christopher J. Evans and MacDonald J. ChristieAnnette C. Dolphin, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 223-254; DOI: https://doi.org/10.1124/pr.112.005942
Christopoulos, Arthur
- You have accessStrategies to Address Low Drug Solubility in Discovery and DevelopmentHywel D. Williams, Natalie L. Trevaskis, Susan A. Charman, Ravi M. Shanker, William N. Charman, Colin W. Pouton and Christopher J. H. PorterArthur Christopoulos, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 315-499; DOI: https://doi.org/10.1124/pr.112.005660
Chuang, De-Maw
- You have accessTherapeutic Potential of Mood Stabilizers Lithium and Valproic Acid: Beyond Bipolar DisorderChi-Tso Chiu, Zhifei Wang, Joshua G. Hunsberger and De-Maw ChuangDavid R. Sibley, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 105-142; DOI: https://doi.org/10.1124/pr.111.005512
D
Davis, Thomas P.
- You have accessTargeted Drug Delivery to Treat Pain and Cerebral HypoxiaPatrick T. Ronaldson and Thomas P. DavisDavid R. Sibley, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 291-314; DOI: https://doi.org/10.1124/pr.112.005991
Daws, Lynette C.
- You have accessThe Flinders Sensitive Line Rat Model of Depression—25 Years and Still ProducingDavid H. Overstreet and Gregers WegenerLynette C. Daws, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 143-155; DOI: https://doi.org/10.1124/pr.111.005397
Di Lullo, Elizabeth
- You have accessHomeoprotein Signaling in Development, Health, and Disease: A Shaking of Dogmas Offers Challenges and Promises from Bench to BedJulien Spatazza, Elizabeth Di Lullo, Alain Joliot, Edmond Dupont, Kenneth L. Moya and Alain ProchiantzGlenda E. Gillies, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 90-104; DOI: https://doi.org/10.1124/pr.112.006577
Dolphin, Annette C.
- You have accessIntegrating Optogenetic and Pharmacological Approaches to Study Neural Circuit Function: Current Applications and Future DirectionsGarret D. Stuber and Alex O. MasonAnnette C. Dolphin, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 156-170; DOI: https://doi.org/10.1124/pr.111.005611
- You have accessRegulation of µ-Opioid Receptors: Desensitization, Phosphorylation, Internalization, and ToleranceJohn T. Williams, Susan L. Ingram, Graeme Henderson, Charles Chavkin, Mark von Zastrow, Stefan Schulz, Thomas Koch, Christopher J. Evans and MacDonald J. ChristieAnnette C. Dolphin, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 223-254; DOI: https://doi.org/10.1124/pr.112.005942
Dupont, Edmond
- You have accessHomeoprotein Signaling in Development, Health, and Disease: A Shaking of Dogmas Offers Challenges and Promises from Bench to BedJulien Spatazza, Elizabeth Di Lullo, Alain Joliot, Edmond Dupont, Kenneth L. Moya and Alain ProchiantzGlenda E. Gillies, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 90-104; DOI: https://doi.org/10.1124/pr.112.006577
E
Evans, Christopher J.
- You have accessRegulation of µ-Opioid Receptors: Desensitization, Phosphorylation, Internalization, and ToleranceJohn T. Williams, Susan L. Ingram, Graeme Henderson, Charles Chavkin, Mark von Zastrow, Stefan Schulz, Thomas Koch, Christopher J. Evans and MacDonald J. ChristieAnnette C. Dolphin, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 223-254; DOI: https://doi.org/10.1124/pr.112.005942
F
Fox, Susan H.
- You have accessThe Pharmacology of l-DOPA-Induced Dyskinesia in Parkinson’s DiseasePhilippe Huot, Tom H. Johnston, James B. Koprich, Susan H. Fox and Jonathan M. BrotchieDavid R. Sibley, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 171-222; DOI: https://doi.org/10.1124/pr.111.005678
Fuchs, Sebastien
- You have accessA Modern Understanding of the Traditional and Nontraditional Biological Functions of Angiotensin-Converting EnzymeKenneth E. Bernstein, Frank S. Ong, Wendell-Lamar B. Blackwell, Kandarp H. Shah, Jorge F. Giani, Romer A. Gonzalez-Villalobos, Xiao Z. Shen and Sebastien FuchsRhian M. Touyz, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 1-46; DOI: https://doi.org/10.1124/pr.112.006809
G
Garland, Christopher J.
- You have accessCC Chemokine Receptors and Chronic Inflammation—Therapeutic Opportunities and Pharmacological ChallengesGemma E. White, Asif J. Iqbal and David R. GreavesChristopher J. Garland, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 47-89; DOI: https://doi.org/10.1124/pr.111.005074
Giani, Jorge F.
- You have accessA Modern Understanding of the Traditional and Nontraditional Biological Functions of Angiotensin-Converting EnzymeKenneth E. Bernstein, Frank S. Ong, Wendell-Lamar B. Blackwell, Kandarp H. Shah, Jorge F. Giani, Romer A. Gonzalez-Villalobos, Xiao Z. Shen and Sebastien FuchsRhian M. Touyz, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 1-46; DOI: https://doi.org/10.1124/pr.112.006809
Gillies, Glenda E.
- You have accessHomeoprotein Signaling in Development, Health, and Disease: A Shaking of Dogmas Offers Challenges and Promises from Bench to BedJulien Spatazza, Elizabeth Di Lullo, Alain Joliot, Edmond Dupont, Kenneth L. Moya and Alain ProchiantzGlenda E. Gillies, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 90-104; DOI: https://doi.org/10.1124/pr.112.006577
Gonzalez-Villalobos, Romer A.
- You have accessA Modern Understanding of the Traditional and Nontraditional Biological Functions of Angiotensin-Converting EnzymeKenneth E. Bernstein, Frank S. Ong, Wendell-Lamar B. Blackwell, Kandarp H. Shah, Jorge F. Giani, Romer A. Gonzalez-Villalobos, Xiao Z. Shen and Sebastien FuchsRhian M. Touyz, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 1-46; DOI: https://doi.org/10.1124/pr.112.006809
Greaves, David R.
- You have accessCC Chemokine Receptors and Chronic Inflammation—Therapeutic Opportunities and Pharmacological ChallengesGemma E. White, Asif J. Iqbal and David R. GreavesChristopher J. Garland, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 47-89; DOI: https://doi.org/10.1124/pr.111.005074
H
Henderson, Graeme
- You have accessRegulation of µ-Opioid Receptors: Desensitization, Phosphorylation, Internalization, and ToleranceJohn T. Williams, Susan L. Ingram, Graeme Henderson, Charles Chavkin, Mark von Zastrow, Stefan Schulz, Thomas Koch, Christopher J. Evans and MacDonald J. ChristieAnnette C. Dolphin, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 223-254; DOI: https://doi.org/10.1124/pr.112.005942
Hunsberger, Joshua G.
- You have accessTherapeutic Potential of Mood Stabilizers Lithium and Valproic Acid: Beyond Bipolar DisorderChi-Tso Chiu, Zhifei Wang, Joshua G. Hunsberger and De-Maw ChuangDavid R. Sibley, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 105-142; DOI: https://doi.org/10.1124/pr.111.005512
Huot, Philippe
- You have accessThe Pharmacology of l-DOPA-Induced Dyskinesia in Parkinson’s DiseasePhilippe Huot, Tom H. Johnston, James B. Koprich, Susan H. Fox and Jonathan M. BrotchieDavid R. Sibley, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 171-222; DOI: https://doi.org/10.1124/pr.111.005678
I
Ingram, Susan L.
- You have accessRegulation of µ-Opioid Receptors: Desensitization, Phosphorylation, Internalization, and ToleranceJohn T. Williams, Susan L. Ingram, Graeme Henderson, Charles Chavkin, Mark von Zastrow, Stefan Schulz, Thomas Koch, Christopher J. Evans and MacDonald J. ChristieAnnette C. Dolphin, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 223-254; DOI: https://doi.org/10.1124/pr.112.005942
Iqbal, Asif J.
- You have accessCC Chemokine Receptors and Chronic Inflammation—Therapeutic Opportunities and Pharmacological ChallengesGemma E. White, Asif J. Iqbal and David R. GreavesChristopher J. Garland, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 47-89; DOI: https://doi.org/10.1124/pr.111.005074
J
Johnston, Tom H.
- You have accessThe Pharmacology of l-DOPA-Induced Dyskinesia in Parkinson’s DiseasePhilippe Huot, Tom H. Johnston, James B. Koprich, Susan H. Fox and Jonathan M. BrotchieDavid R. Sibley, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 171-222; DOI: https://doi.org/10.1124/pr.111.005678
Joliot, Alain
- You have accessHomeoprotein Signaling in Development, Health, and Disease: A Shaking of Dogmas Offers Challenges and Promises from Bench to BedJulien Spatazza, Elizabeth Di Lullo, Alain Joliot, Edmond Dupont, Kenneth L. Moya and Alain ProchiantzGlenda E. Gillies, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 90-104; DOI: https://doi.org/10.1124/pr.112.006577
K
Kelly, T. H.
- You have accessIndividual Differences and Social Influences on the Neurobehavioral Pharmacology of Abused DrugsM. T. Bardo, J. L. Neisewander and T. H. KellyMichael A. Nader, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 255-290; DOI: https://doi.org/10.1124/pr.111.005124
Klos, Andreas
- You have accessInternational Union of Basic and Clinical Pharmacology. LXXXVII. Complement Peptide C5a, C4a, and C3a ReceptorsAndreas Klos, Elisabeth Wende, Kathryn J. Wareham and Peter N. MonkPharmacological Reviews January 2013, 65 (1) 500-543; DOI: https://doi.org/10.1124/pr.111.005223
Koch, Thomas
- You have accessRegulation of µ-Opioid Receptors: Desensitization, Phosphorylation, Internalization, and ToleranceJohn T. Williams, Susan L. Ingram, Graeme Henderson, Charles Chavkin, Mark von Zastrow, Stefan Schulz, Thomas Koch, Christopher J. Evans and MacDonald J. ChristieAnnette C. Dolphin, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 223-254; DOI: https://doi.org/10.1124/pr.112.005942
Koprich, James B.
- You have accessThe Pharmacology of l-DOPA-Induced Dyskinesia in Parkinson’s DiseasePhilippe Huot, Tom H. Johnston, James B. Koprich, Susan H. Fox and Jonathan M. BrotchieDavid R. Sibley, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 171-222; DOI: https://doi.org/10.1124/pr.111.005678
M
Mason, Alex O.
- You have accessIntegrating Optogenetic and Pharmacological Approaches to Study Neural Circuit Function: Current Applications and Future DirectionsGarret D. Stuber and Alex O. MasonAnnette C. Dolphin, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 156-170; DOI: https://doi.org/10.1124/pr.111.005611
Monk, Peter N.
- You have accessInternational Union of Basic and Clinical Pharmacology. LXXXVII. Complement Peptide C5a, C4a, and C3a ReceptorsAndreas Klos, Elisabeth Wende, Kathryn J. Wareham and Peter N. MonkPharmacological Reviews January 2013, 65 (1) 500-543; DOI: https://doi.org/10.1124/pr.111.005223
Moya, Kenneth L.
- You have accessHomeoprotein Signaling in Development, Health, and Disease: A Shaking of Dogmas Offers Challenges and Promises from Bench to BedJulien Spatazza, Elizabeth Di Lullo, Alain Joliot, Edmond Dupont, Kenneth L. Moya and Alain ProchiantzGlenda E. Gillies, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 90-104; DOI: https://doi.org/10.1124/pr.112.006577
N
Nader, Michael A.
- You have accessIndividual Differences and Social Influences on the Neurobehavioral Pharmacology of Abused DrugsM. T. Bardo, J. L. Neisewander and T. H. KellyMichael A. Nader, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 255-290; DOI: https://doi.org/10.1124/pr.111.005124
Neisewander, J. L.
- You have accessIndividual Differences and Social Influences on the Neurobehavioral Pharmacology of Abused DrugsM. T. Bardo, J. L. Neisewander and T. H. KellyMichael A. Nader, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 255-290; DOI: https://doi.org/10.1124/pr.111.005124
O
Ong, Frank S.
- You have accessA Modern Understanding of the Traditional and Nontraditional Biological Functions of Angiotensin-Converting EnzymeKenneth E. Bernstein, Frank S. Ong, Wendell-Lamar B. Blackwell, Kandarp H. Shah, Jorge F. Giani, Romer A. Gonzalez-Villalobos, Xiao Z. Shen and Sebastien FuchsRhian M. Touyz, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 1-46; DOI: https://doi.org/10.1124/pr.112.006809
Overstreet, David H.
- You have accessThe Flinders Sensitive Line Rat Model of Depression—25 Years and Still ProducingDavid H. Overstreet and Gregers WegenerLynette C. Daws, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 143-155; DOI: https://doi.org/10.1124/pr.111.005397
P
Porter, Christopher J. H.
- You have accessStrategies to Address Low Drug Solubility in Discovery and DevelopmentHywel D. Williams, Natalie L. Trevaskis, Susan A. Charman, Ravi M. Shanker, William N. Charman, Colin W. Pouton and Christopher J. H. PorterArthur Christopoulos, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 315-499; DOI: https://doi.org/10.1124/pr.112.005660
Pouton, Colin W.
- You have accessStrategies to Address Low Drug Solubility in Discovery and DevelopmentHywel D. Williams, Natalie L. Trevaskis, Susan A. Charman, Ravi M. Shanker, William N. Charman, Colin W. Pouton and Christopher J. H. PorterArthur Christopoulos, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 315-499; DOI: https://doi.org/10.1124/pr.112.005660
Prochiantz, Alain
- You have accessHomeoprotein Signaling in Development, Health, and Disease: A Shaking of Dogmas Offers Challenges and Promises from Bench to BedJulien Spatazza, Elizabeth Di Lullo, Alain Joliot, Edmond Dupont, Kenneth L. Moya and Alain ProchiantzGlenda E. Gillies, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 90-104; DOI: https://doi.org/10.1124/pr.112.006577
R
Ronaldson, Patrick T.
- You have accessTargeted Drug Delivery to Treat Pain and Cerebral HypoxiaPatrick T. Ronaldson and Thomas P. DavisDavid R. Sibley, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 291-314; DOI: https://doi.org/10.1124/pr.112.005991
S
Schulz, Stefan
- You have accessRegulation of µ-Opioid Receptors: Desensitization, Phosphorylation, Internalization, and ToleranceJohn T. Williams, Susan L. Ingram, Graeme Henderson, Charles Chavkin, Mark von Zastrow, Stefan Schulz, Thomas Koch, Christopher J. Evans and MacDonald J. ChristieAnnette C. Dolphin, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 223-254; DOI: https://doi.org/10.1124/pr.112.005942
Shah, Kandarp H.
- You have accessA Modern Understanding of the Traditional and Nontraditional Biological Functions of Angiotensin-Converting EnzymeKenneth E. Bernstein, Frank S. Ong, Wendell-Lamar B. Blackwell, Kandarp H. Shah, Jorge F. Giani, Romer A. Gonzalez-Villalobos, Xiao Z. Shen and Sebastien FuchsRhian M. Touyz, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 1-46; DOI: https://doi.org/10.1124/pr.112.006809
Shanker, Ravi M.
- You have accessStrategies to Address Low Drug Solubility in Discovery and DevelopmentHywel D. Williams, Natalie L. Trevaskis, Susan A. Charman, Ravi M. Shanker, William N. Charman, Colin W. Pouton and Christopher J. H. PorterArthur Christopoulos, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 315-499; DOI: https://doi.org/10.1124/pr.112.005660
Shen, Xiao Z.
- You have accessA Modern Understanding of the Traditional and Nontraditional Biological Functions of Angiotensin-Converting EnzymeKenneth E. Bernstein, Frank S. Ong, Wendell-Lamar B. Blackwell, Kandarp H. Shah, Jorge F. Giani, Romer A. Gonzalez-Villalobos, Xiao Z. Shen and Sebastien FuchsRhian M. Touyz, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 1-46; DOI: https://doi.org/10.1124/pr.112.006809
Sibley, David R.
- You have accessTherapeutic Potential of Mood Stabilizers Lithium and Valproic Acid: Beyond Bipolar DisorderChi-Tso Chiu, Zhifei Wang, Joshua G. Hunsberger and De-Maw ChuangDavid R. Sibley, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 105-142; DOI: https://doi.org/10.1124/pr.111.005512
- You have accessThe Pharmacology of l-DOPA-Induced Dyskinesia in Parkinson’s DiseasePhilippe Huot, Tom H. Johnston, James B. Koprich, Susan H. Fox and Jonathan M. BrotchieDavid R. Sibley, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 171-222; DOI: https://doi.org/10.1124/pr.111.005678
- You have accessTargeted Drug Delivery to Treat Pain and Cerebral HypoxiaPatrick T. Ronaldson and Thomas P. DavisDavid R. Sibley, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 291-314; DOI: https://doi.org/10.1124/pr.112.005991
Spatazza, Julien
- You have accessHomeoprotein Signaling in Development, Health, and Disease: A Shaking of Dogmas Offers Challenges and Promises from Bench to BedJulien Spatazza, Elizabeth Di Lullo, Alain Joliot, Edmond Dupont, Kenneth L. Moya and Alain ProchiantzGlenda E. Gillies, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 90-104; DOI: https://doi.org/10.1124/pr.112.006577
Stuber, Garret D.
- You have accessIntegrating Optogenetic and Pharmacological Approaches to Study Neural Circuit Function: Current Applications and Future DirectionsGarret D. Stuber and Alex O. MasonAnnette C. Dolphin, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 156-170; DOI: https://doi.org/10.1124/pr.111.005611
T
Touyz, Rhian M.
- You have accessA Modern Understanding of the Traditional and Nontraditional Biological Functions of Angiotensin-Converting EnzymeKenneth E. Bernstein, Frank S. Ong, Wendell-Lamar B. Blackwell, Kandarp H. Shah, Jorge F. Giani, Romer A. Gonzalez-Villalobos, Xiao Z. Shen and Sebastien FuchsRhian M. Touyz, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 1-46; DOI: https://doi.org/10.1124/pr.112.006809
Trevaskis, Natalie L.
- You have accessStrategies to Address Low Drug Solubility in Discovery and DevelopmentHywel D. Williams, Natalie L. Trevaskis, Susan A. Charman, Ravi M. Shanker, William N. Charman, Colin W. Pouton and Christopher J. H. PorterArthur Christopoulos, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 315-499; DOI: https://doi.org/10.1124/pr.112.005660
V
von Zastrow, Mark
- You have accessRegulation of µ-Opioid Receptors: Desensitization, Phosphorylation, Internalization, and ToleranceJohn T. Williams, Susan L. Ingram, Graeme Henderson, Charles Chavkin, Mark von Zastrow, Stefan Schulz, Thomas Koch, Christopher J. Evans and MacDonald J. ChristieAnnette C. Dolphin, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 223-254; DOI: https://doi.org/10.1124/pr.112.005942
W
Wang, Zhifei
- You have accessTherapeutic Potential of Mood Stabilizers Lithium and Valproic Acid: Beyond Bipolar DisorderChi-Tso Chiu, Zhifei Wang, Joshua G. Hunsberger and De-Maw ChuangDavid R. Sibley, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 105-142; DOI: https://doi.org/10.1124/pr.111.005512
Wareham, Kathryn J.
- You have accessInternational Union of Basic and Clinical Pharmacology. LXXXVII. Complement Peptide C5a, C4a, and C3a ReceptorsAndreas Klos, Elisabeth Wende, Kathryn J. Wareham and Peter N. MonkPharmacological Reviews January 2013, 65 (1) 500-543; DOI: https://doi.org/10.1124/pr.111.005223
Wegener, Gregers
- You have accessThe Flinders Sensitive Line Rat Model of Depression—25 Years and Still ProducingDavid H. Overstreet and Gregers WegenerLynette C. Daws, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 143-155; DOI: https://doi.org/10.1124/pr.111.005397
Wende, Elisabeth
- You have accessInternational Union of Basic and Clinical Pharmacology. LXXXVII. Complement Peptide C5a, C4a, and C3a ReceptorsAndreas Klos, Elisabeth Wende, Kathryn J. Wareham and Peter N. MonkPharmacological Reviews January 2013, 65 (1) 500-543; DOI: https://doi.org/10.1124/pr.111.005223
White, Gemma E.
- You have accessCC Chemokine Receptors and Chronic Inflammation—Therapeutic Opportunities and Pharmacological ChallengesGemma E. White, Asif J. Iqbal and David R. GreavesChristopher J. Garland, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 47-89; DOI: https://doi.org/10.1124/pr.111.005074
Williams, Hywel D.
- You have accessStrategies to Address Low Drug Solubility in Discovery and DevelopmentHywel D. Williams, Natalie L. Trevaskis, Susan A. Charman, Ravi M. Shanker, William N. Charman, Colin W. Pouton and Christopher J. H. PorterArthur Christopoulos, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 315-499; DOI: https://doi.org/10.1124/pr.112.005660
Williams, John T.
- You have accessRegulation of µ-Opioid Receptors: Desensitization, Phosphorylation, Internalization, and ToleranceJohn T. Williams, Susan L. Ingram, Graeme Henderson, Charles Chavkin, Mark von Zastrow, Stefan Schulz, Thomas Koch, Christopher J. Evans and MacDonald J. ChristieAnnette C. Dolphin, ASSOCIATE EDITORPharmacological Reviews January 2013, 65 (1) 223-254; DOI: https://doi.org/10.1124/pr.112.005942
In this issue
Advertisement